Skip to main content

The Role of Pseudotype Neutralisation Assays in Understanding SARS CoV-2

Cantoni, Diego, Mayora-Neto, Martin, Temperton, Nigel J. (2021) The Role of Pseudotype Neutralisation Assays in Understanding SARS CoV-2. Oxford Open Immunology, . Article Number iqab005. E-ISSN 2633-6960. (doi:10.1093/oxfimm/iqab005) (KAR id:86594)

PDF Author's Accepted Manuscript
Language: English

Download (266kB) Preview
[thumbnail of iqab005.pdf]
This file may not be suitable for users of assistive technology.
Request an accessible format
Official URL


Neutralisation assays are crucial tools to quantify the presence of functional neutralising antibodies in serum samples. Since the SARS-CoV-2 virus (the causative agent of COVID-19) is designated as a category 3 biosafety level pathogen, pseudotyped viruses bearing the SARS-CoV-2 spike protein permit extensive and widespread serum/plasma screening in a BSL 2 laboratory. These assays can be used to assess viral tropism, vaccine immunogenicity, efficacy of antiviral compounds (incl. therapeutic mAbs) and serosurveillance studies. In this article, we highlight approaches to SARS-CoV-2 viral pseudotyping, its practicality, and utility in increasing our understanding of neutralising antibodies against SARS-CoV-2.

Item Type: Article
DOI/Identification number: 10.1093/oxfimm/iqab005
Uncontrolled keywords: COVID-19, SARS CoV-2, neutralisation assays
Subjects: Q Science > QR Microbiology > QR355 Virology
Divisions: Divisions > Division of Natural Sciences > Medway School of Pharmacy
Depositing User: Nigel Temperton
Date Deposited: 14 Feb 2021 16:10 UTC
Last Modified: 16 Feb 2021 14:18 UTC
Resource URI: (The current URI for this page, for reference purposes)
Temperton, Nigel J.:
  • Depositors only (login required):


Downloads per month over past year